Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 243 of 243 entries
Sorted by: Best Match Show Resources per page
How to engage patient partners in health service research: a scoping review protocol.

Research involvement and engagement

Tscherning SC, Bekker HL, Vedelø TW, Finderup J, Rodkjær LØ.
PMID: 33902753
Res Involv Engagem. 2021 Apr 26;7(1):20. doi: 10.1186/s40900-021-00268-z.

BACKGROUND: The patients' and the carers' roles in health service research has changed from being solely participants in studies to also being active partners and co-designers in the research process. Research carried out with or by patient partners is...

Cite
Tscherning SC, Bekker HL, Vedelø TW, et al. How to engage patient partners in health service research: a scoping review protocol. Res Involv Engagem. 2021;7(1):20doi: 10.1186/s40900-021-00268-z.
Tscherning, S. C., Bekker, H. L., Vedelø, T. W., Finderup, J., & Rodkjær, L. �. �. (2021). How to engage patient partners in health service research: a scoping review protocol. Research involvement and engagement, 7(1), 20. https://doi.org/10.1186/s40900-021-00268-z
Tscherning, Sarah Cecilie, et al. "How to engage patient partners in health service research: a scoping review protocol." Research involvement and engagement vol. 7,1 (2021): 20. doi: https://doi.org/10.1186/s40900-021-00268-z
Tscherning SC, Bekker HL, Vedelø TW, Finderup J, Rodkjær LØ. How to engage patient partners in health service research: a scoping review protocol. Res Involv Engagem. 2021 Apr 26;7(1):20. doi: 10.1186/s40900-021-00268-z. PMID: 33902753; PMCID: PMC8073888.
Copy Download .nbib Format: NLM
Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity.

Stroke

Johansen MC, Gottesman RF, Kral BG, Vaidya D, Yanek LR, Becker LC, Becker DM, Nyquist P.
PMID: 34000829
Stroke. 2021 Aug;52(8):2594-2600. doi: 10.1161/STROKEAHA.120.032674. Epub 2021 May 18.

BACKGROUND AND PURPOSE: We aim to determine, in healthy high-risk adults, the association between subclinical coronary artery disease and white matter hyperintensity (WMH) volume and location, independent of atherosclerotic risk factors.METHODS: Seven hundred eighty-two asymptomatic first-degree relatives of index...

Cite
Johansen MC, Gottesman RF, Kral BG, et al. Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity. Stroke. 2021;52(8):2594-2600doi: 10.1161/STROKEAHA.120.032674.
Johansen, M. C., Gottesman, R. F., Kral, B. G., Vaidya, D., Yanek, L. R., Becker, L. C., Becker, D. M., & Nyquist, P. (2021). Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity. Stroke, 52(8), 2594-2600. https://doi.org/10.1161/STROKEAHA.120.032674
Johansen, Michelle C, et al. "Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity." Stroke vol. 52,8 (2021): 2594-2600. doi: https://doi.org/10.1161/STROKEAHA.120.032674
Johansen MC, Gottesman RF, Kral BG, Vaidya D, Yanek LR, Becker LC, Becker DM, Nyquist P. Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity. Stroke. 2021 Aug;52(8):2594-2600. doi: 10.1161/STROKEAHA.120.032674. Epub 2021 May 18. PMID: 34000829; PMCID: PMC8316285.
Copy Download .nbib Format: NLM
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.

American journal of clinical oncology

Punekar SR, Griffin MM, Masri L, Roman SD, Makarov DV, Sherman SE, Becker DJ.
PMID: 34753883
Am J Clin Oncol. 2021 Dec 01;44(12):597-602. doi: 10.1097/COC.0000000000000875.

OBJECTIVES: Treatment with epidermal growth factor receptor monoclonal antibodies extends life for patients with advanced colorectal cancers (CRCs) whose tumors exhibit wild-type KRAS, but KRAS testing may be underused. We studied the role of socioeconomic factors in the application...

Cite
Punekar SR, Griffin MM, Masri L, et al. Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. Am J Clin Oncol. 2021;44(12):597-602doi: 10.1097/COC.0000000000000875.
Punekar, S. R., Griffin, M. M., Masri, L., Roman, S. D., Makarov, D. V., Sherman, S. E., & Becker, D. J. (2021). Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. American journal of clinical oncology, 44(12), 597-602. https://doi.org/10.1097/COC.0000000000000875
Punekar, Salman R, et al. "Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer." American journal of clinical oncology vol. 44,12 (2021): 597-602. doi: https://doi.org/10.1097/COC.0000000000000875
Punekar SR, Griffin MM, Masri L, Roman SD, Makarov DV, Sherman SE, Becker DJ. Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. Am J Clin Oncol. 2021 Dec 01;44(12):597-602. doi: 10.1097/COC.0000000000000875. PMID: 34753883.
Copy Download .nbib Format: NLM
Showing 241 to 243 of 243 entries